Related Experiment Video

Updated: Aug 9, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Emerging risk factors and assessment of organ damage in postmenopausal hypertensive women

R Noto1, G Molino, G Sciacchitano

  • 1Department of Internal Medicine and Systemic Pathologies, University of Catania, Catania, Italy.

Panminerva Medica
|July 12, 2003
PubMed

Insights

Postmenopausal women with hypertension face evolving cerebrocardiovascular risk. New approaches assess emerging factors and organ damage for better treatment outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Gerontology

Background:

  • Postmenopausal women, especially those with hypertension, have numerous risk factors for acute cerebrocardiovascular events.
  • Risk stratification requires considering blood pressure, other risk factors, and organ damage.

Purpose of the Study:

  • Investigate emerging factors like endothelial dysfunction, adhesion molecules, and homocysteine as markers of organ damage.
  • Examine the role of carotid intima-media thickness, cardiac imaging, and 24-hour ambulatory blood pressure monitoring (ABPM) in detecting organ damage.

Main Methods:

  • Assessment of endothelial dysfunction.
  • Measurement of adhesion molecules and homocysteine levels.
  • Utilization of carotid ultrasound intima-media thickness, cardiac ultrasound, and 24-hour ABPM.

Main Results:

  • Conventional cerebrocardiovascular risk stratification is changing for postmenopausal hypertensives.
  • Emerging factors are increasingly assessed alongside traditional risk factors.
  • Organ damage assessment is vital for predicting disease development and outcomes.

Conclusions:

  • A multidisciplinary approach is essential for managing cerebrocardiovascular risk in postmenopausal hypertensive women.
  • Integrating emerging factors and organ damage assessment improves risk stratification and treatment.
  • Pharmacological interventions guided by comprehensive assessment can positively influence outcomes.

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.